tirzepatide 60mg/3ml 60mg disposable pen and 3ml Cartridge for Weight Loss Tirzepatide 60 mg: complete guide

Tirzepatide, a dual glucagon-like peptide-1 (GIP) and GLP-1RAs, administered once weekly at a 15 mg dose, resulted in an average weight loss of 20.9% over 72 weeks (Jastreboff et al., 2022), driven by its synergistic effects on appetite regulation, energy intake reduction, and fat mass decrease (Heise et al., 2023)

Timeline: When Tirzepatide Headaches Peak and Resolve Clinical trial data from tirzepatide development shows that headache incidence peaks during the first month of treatment, affecting approximately 2028% of participants

Jakie skutki uboczne maj GLP-1

Consult a healthcare professional before combining it with other supplements

So maybe the drug needs to be used in combination with a sensible diet and exercise regime, if the weight is to stay off